• Lung-Sparing Treatment Options for Malignant Pleural Mesothelioma

    by  • May 14, 2013

    Malignant pleural mesothelioma is a thoracic disease process that affects those with prior inhalational exposure to asbestos. It originates in the pleural space and progresses by local extension to involve the ipsilateral lung and adjacent structures. Often, there is a very long and variable latency period (from exposure to disease manifestation) that can range...

    Read more →

    Treating Extremity Sarcoma

    by  • May 13, 2013

    Extremity sarcoma is one of the hardest cancers to treat. Treatment for patients where sarcoma is in an arm or a leg may include surgery, radiation therapy, chemotherapy, interferon therapy, biologic/immunotherapy and/or innovative therapies using new drugs to fight the disease. With Isolated Limb Infusion (ILI), the effects of chemotherapy can be concentrated regionally...

    Read more →

    What Goes Into Cancer Staging?

    by  • May 9, 2013

    The staging process should begin during an office visit. The history of the patient’s illness and the physical examination often provide important clues about the tumor and whether it has spread. Some cancers can be seen, some can be felt, and examination may reveal body changes that are signs of tumor spread. Even if...

    Read more →

    Dr. Knudson and the Two-Hit Theory

    by  • April 30, 2013

    Fox Chase researcher Alfred G. Knudson Jr., MD, PhD, was recently inaugurated into the first class of the Fellows of the AACR Academy at the AACR Annual Meeting 2013, held in Washington, D.C. The inaugural group of fellows of the academy consists of 106 individuals, symbolizing the age of the organization upon establishment of...

    Read more →

    Minimally Invasive Esophagectomy: A Better Surgical Option for Patients with Esophageal Cancer

    by  • April 26, 2013

    In 2012, the American Cancer Society estimated the annual number of new esophageal cancers at 17,460. Surgical resection with radical lymph node dissection, usually performed after a patient receives either preoperative chemotherapy or chemoradiation, is regarded as the only curative option for resectable esophageal cancer. Surgical removal of the esophagus and reconstruction of the...

    Read more →

    What is Genetic Testing?

    by  • April 25, 2013

    Genetic testing is a blood test that looks for changes, also called alterations or mutations, in genes. These changes cause disease or place someone at higher risk for getting a certain disease, such as cancer. Sometimes these gene changes can be passed from parent to child. Genetic testing, as part of cancer risk assessment,...

    Read more →

    Fatigue and Cancer Treatment

    by  • April 24, 2013

    Fatigue, or feeling tired, is a common side effect of cancer treatment. But patients don’t have to lie down when it comes to dealing with it. Fox Chase has a program that teaches patients how to manage fatigue using a multi-faceted approach. “Fatigue is one of the primary complaints of cancer patients, no matter...

    Read more →